october, 2016

25octalldayalldayAdvancing Rare Disease Drug Discovery: The need for successful collaborationsNew York City


Event Details

What are the elements of a successful collaboration? Who can contribute to the project? How do you build your team? How do you structure leadership, establish goals and create accountability within a collaboration?

We’ll discuss these questions and review examples of successful collaborations in this complimentary one-day symposium hosted by Charles River. During the symposium, rare disease researchers will network with academic and industry leaders, share best practices and review case studies of successful collaborative discovery programs. The agenda also includes discussions on the role of genomics in rare disease drug development.

Join us at a symposium hosted by Charles River on October 25, 2016 in New York City to participate in the discussion and distill new insights from several prolific, venerable and successful collaborations in the field. 

Have something to share? Stimulate discussion and encourage interaction by participating in our poster session and be eligible to win a $250 gift card. Contributions are welcome, but space is limited. Simply submit your abstract by October 11th by emailing lisa.antolick@crl.com

Featured speakers include Dominic Wells (Royal Veterinary College), Matthew Harms (Columbia University), Carl Morris (Solid Biosciences), Jim Rosinski (CHDI Foundation), Tuuli Lappalainen (New York Genome Center), Brian Wamhoff (Hemoshear Therapeutics), Jill Weimer (Sanford Research) and Chris Lock (Charles River). The symposium will be moderated by the award winning journalist and producer of RARECast podcasts Daniel S. Levine.


All Day (Tuesday)


Convene conference center

New York, NY